Published in Cancer Weekly, June 19th, 2007
A prospective, randomized, multicenter Phase III study was conducted to compare ALIMTA plus carboplatin with the commonly used regimen of GEMZAR(R) (gemcitabine HC1 for injection) plus carboplatin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly